Fig. 3From: Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: a retrospective analysisROC curve analysis of pretreatment serum FFAs levels (AUC=0.602,95% CI 0.510-0.694, P=0.038)Back to article page